274
Views
3
CrossRef citations to date
0
Altmetric
Letter

Successful treatment of post-transplant Epstein–Barr virus-related meningoencephalitis by intravenous rituximab monotherapy

, , , , , , , , , , , , & show all
Pages 2063-2065 | Received 06 Jan 2012, Accepted 18 Feb 2012, Published online: 19 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Oluf Andersen, Ingemar Ernberg & Anna Karin Hedström. (2023) Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System. Infection and Drug Resistance 16, pages 4599-4620.
Read now

Articles from other publishers (2)

Walter Barberi, Salvatore Perrone, Anna Paola Iori, Giovanni Fernando Torelli, Anna Maria Testi, Maria Luisa Moleti, Teresa Ceglie, Paola Papoff, Elena Caresta, Manila Antonelli, Francesca Gianno, Antonio Melone, Manuela Badiali, Felice Giangaspero, Robin Foà & Giuseppe Gentile. (2014) Proven E pstein– B arr encephalitis with negative EBV ‐ DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia . Pediatric Transplantation 19:1.
Crossref
Bruce A. Cohen & Valentina Stosor. (2013) Opportunistic Infections of the Central Nervous System in the Transplant Patient. Current Neurology and Neuroscience Reports 13:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.